Rationale: Lung hypoplasia in congenital diaphragmatic hernia (CDH) seems to involve impaired alveolar septation. We hypothesized that disturbed deposition of elastin and expression of fibroblast growth factor 18 (FGF18), an elastogenesis stimulus, occurs in CDH. Objectives: To document FGF18 and elastin in human CDH and ovine surgical and rat nitrofen models and to use models to evaluate the benefit of treatments. Methods: Human CDH and control lungs were collected post mortem. Diaphragmatic hernia was created in sheep at 85 days; fetal lungs were collected at 139 days (term ϭ 145 days). Pregnant rats received nitrofen at 12 days; fetal lungs were collected at 21 days (term ϭ 22 days). Some of the sheep fetuses with hernia underwent tracheal occlusion (TO); some of the nitrofen-treated pregnant rats received vitamin A. Both treatments are known to promote lung growth.
AT A GLANCE COMMENTARY Scientific Knowledge on the Subject
The pathogenesis of lung hypoplasia in congenital diaphragmatic hernia (CDH) remains imperfectly understood.
What This Study Adds to the Field
Impaired septation in CDH is associated with decreased FGF18 expression and elastin deposition. Simultaneous correction of FGF18 and elastin defects by tracheal occlusion suggests that defective elastogenesis may result in part from FGF18 deficiency. bronchiolar end giving rise to a limited number of saccules. Changes in key control factors involved in branching morphogenesis have been consistently reported. The sonic hedgehog system was lowered at early stages in CDH and peaked later in humans and in a rat model of CDH induced by the herbicide nitrofen (7) . Fibroblast growth factor (FGF) 10 was decreased in the nitrofen model (8) . The expression of FGF7, known to control alveolar epithelial cell proliferation and differentiation, was decreased in the nitrofen model (8) and in a model of surgically induced CDH in sheep (9) .
Morphogenesis of distal lung, including alveolar septation, also seems to be impaired in CDH. This disorder is a common feature of hypoplastic lungs. Thus, previous studies in human pulmonary hypoplasia of various origins, including hydrops fetalis, renal anomalies, oligohydramnios, and CDH, have established retarded acinar complexity and maturation (10, 11) . Elastic fiber deposition, which is essential to build alveolar walls (16) (17) (18) , was reported to be disturbed in human lung hypoplasia in association with oligohydramnios (15) (16) (17) or CDH (17) and experimentally in drainage-induced lung hypoplasia in fetal sheep (18) . Moreover, in the ovine model, alveolar hypoplasia occurred in the absence of reduction in bronchiolar generations due to late creation of hernia (19) , and discontinuous, uncondensed elastin aggregates have been described in alveolar septa (20) . Decreased elastin expression with less elastin deposition and disorganized distribution have also been reported in the nitrofen model (21) .
Compared with branching morphogenesis, less is known about mechanisms that control saccular and alveolar development. FGF18 is believed to play important role. Thus, lungtargeted FGF18 overexpression inhibited distal lung development (22) , whereas FGF18-null mouse fetuses displayed smaller distal airspaces and thickened septa (23) . FGF18 expression markedly increases coincidently with postnatal formation of secondary septa in the rat (24) , and FGF18 enhances proliferation and elastogenesis in myofibroblasts (24) , the source of septal elastin. Moreover, FGFR3 is a high-affinity receptor for FGF18 (25) , and alveolarization is abolished in mice devoid of FGFR3 and FGFR4 (26) . FGF18 has not been documented in the developing human lung in normal or pathologic conditions.
The potential benefit of two treatments aiming to restore lung development in CDH, tracheal occlusion (TO) and vitamin A administration, have been investigated in the surgical ovine model and in the rat nitrofen model, respectively. In sheep fetuses with hernia and lung hypoplasia induced by drainage, TO restored lung growth, increased gas exchange surface area (27) (28) (29) , and ameliorated respiratory function at delivery (30, 31) . This treatment is under trial in human fetuses with CDH (32) . In the nitrofen model, vitamin A decreased the incidence and severity of CDH, enhanced lung growth, and restored lung maturation (33, 34) .
The first objective of the present study was to investigate whether CDH affected FGF18 expression in the developing human lung and in models. Elastic fiber deposits and elastin expression were studied in parallel to further document qualitative and quantitative changes. The second objective consisted of using the sheep and rat models of CDH to evaluate the effects of TO and vitamin A treatment, respectively, on pulmonary FGF18 expression and elastin deposition. Some of the results of these studies have been previously reported in the form of an abstract (35) .
METHODS

Human Lung Tissue
Human lung samples were collected during the autopsy after medical terminations of pregnancy in bad-prognosis fetuses or after death post- delivery. Parents were informed about the procedure and issues of post mortem study, and signed consent was obtained for all included patients. The study received approval from the local Ethics Committee. Detailed clinical data are depicted in Table 1 .
Sheep Model of CDH and TO
Surgical procedures have been extensively described elsewhere (36) . Biological samples were collected from the same animals as in previous reports (20, 27) .
Nitrofen Exposure in Rats
The procedure has been described in detail elsewhere (33) . Pregnant Wistar rats were gavaged with nitrofen in olive oil on Day 12. Control dams received olive oil. They were gavaged with vitamin A on Day 14. Fetuses were retrieved on Day 21.
Histochemical Elastin Staining and Quantification
Because of restrictions in human tissue sampling conditions and of collection of sheep lung samples for multiple purposes (20, 27) , lungs were not fixed at constant pressure. Human and sheep lungs tissue were fixed 24 hours after death and at death, respectively. Sections were stained for elastin with Weigert's stain. The proportion of tissue surface area occupied by elastic fibers was determined with Perfect Image v7.4 software (ClaraVision, Massy, France). In each analyzed field, tissue area was determined by subtracting airspace surface area from total surface area. Stained elastic fiber surface area was measured after exclusion of large-vessel and airway elastin.
Immunohistochemical FGF18 Analyses
Sections were labeled using a polyclonal antibody raised in rabbit (AbCys S.A., Paris, France) and Cy3-conjugated donkey anti-rabbit IgG (Jackson ImmunoResearch, Newmarket, UK).
RNA Extraction
Total RNA was extracted using Trizol reagent (Invitrogen, CergyPontoise, France). Quality and integrity were confirmed after electrophoresis. Determination of Ovine Partial cDNA Sequence for FGF18
cDNAs were reverse-transcribed from sheep lung total RNAs, and amplification of partial cDNA sequence was performed using sense primer 5Ј-CTGCTGTGCTTCCAGGTTCA-3Ј (mouse/rat FGF18-specific sequence; GenBank accession numbers NM008005 and NM019199, respectively) and antisense primer 5Ј-CCGTCGTGTACTTGAAGGGC-3Ј (human FGF18-specific sequence; GenBank accession number BC006245).
Northern Blot Analysis
Rat cDNA probes consisted of a 1,100-bp sequence for tropoelastin (gift from Dr. C. Rich, Philadelphia, PA) and a 904-bp sequence for FGF18 (gift from Dr. N. Itoh, Kyoto, Japan). Ovine tropoelastin cDNA probe was obtained by reverse transcriptase (RT)-PCR from RNA extracted from fetal sheep lung tissue using ovine-specific oligonucleotide primers (37) . Blots were exposed to X-Omat AR Kodak films (Sigma, L'Isle d'Abeau, France), and signals were quantified by densitometry (NIH Image, Bethesda, MD).
Reverse Transcription and Real-Time Quantitative Polymerase Chain Reaction
Real-time polymerase chain reaction (PCR) (⌬⌬Ct [threshold cycle] method) was performed to determine the amounts of FGF18 mRNA, FGFR3 mRNA, and internal reference 18S rRNA in ovine lungs. Primer sequences are reported in Table 2 . All measurements were performed in triplicate.
Western Blot Analysis
Membranes were exposed to goat anti-rhFGF18 antibody (R&D Systems, Lille, France) diluted 1:500, washed in Tween-20 Tris-buffered Saline (TTBS), and exposed to horseradish peroxidase-conjugated donkey anti-goat IgG antibody (Santa Cruz Biotechnology, Santa Cruz, CA) and incubated in enhanced chemiluminescence (ECL) reagent (Amersham Biosciences) before exposure to Kodak BioMax MS film. Signals were quantified by densitometry (NIH image).
Statistical Analysis
Data are presented as mean Ϯ SE. Multiple group comparisons were made by analysis of variance and Fisher's protected least significant difference or by nonparametric Kruskal-Wallis analysis, depending on applicability as detailed in Results. Two-group comparisons were made by Student's t test or by nonparametric Mann-Whitney U test, depending on applicability.
RESULTS
FGF18 in Human Lungs with CDH
FGF18 protein was studied in human lung samples by Western blot analysis. Preservation of RNA was not constant enough for us to perform a study at the pretranslational level. Because FGF18 had never been documented in developing human lung, a first step consisted in studying changes in FGF18 level during the course of intrauterine development. The FGF18 proportion increased with progressing pregnancy between 14 and 37 weeks (fetal age) with a particularly marked rise around 28 weeks alveolar stages) were then studied comparatively ( Figure 2A ). All CDH lungs ipsilateral to hernia displayed lower FGF18 levels than their respective age-matched controls, and FGF18 failed to increase in CDH samples over the period, whereas control values increased by about three times ( Figure 2B ).
Elastin in Human Lungs with CDH
Elastin staining was performed in five pairs of control and CDH lungs ranging from 27 to 37 weeks. In control fetuses, lung parenchyma matured homogeneously during the period, with thinning of septal walls, increased proportion of airspaces, and a surge of secondary septa ( Figures 3A and 3C ). Airspaces displayed regular distribution. Elastin staining demonstrated bundles beneath the surface of walls and punctate, dense deposits at the tips of growing septa that considerably increased in number with maturation ( Figures 3AЈ and 3CЈ ). Consistent with previous reports, CDH lungs displayed thicker walls and denser tissue ( Figures 3B and 3D ). Elastin staining also demonstrated mostly bundles in thick septa with an extreme paucity of tip deposits ( Figures 3BЈ and 3DЈ) , which illustrates deficient secondary septation. Lung vessels strongly stained for elastin and presented no noticeable difference between CDH and control lungs. Quantitative evaluation of parenchymal elastic fiber deposits was achieved by determination of the proportion of tissue surface area occupied by elastin patches, excluding vessel and airway elastin (Table 3 ). The elastic fiber density was low at 27 and 29 weeks, with no difference between CDH and control lungs. It was considerably higher at 31, 33, and 37 weeks in control subjects but failed to increase in CDH lungs, which displayed much lower values than their respective age-matched control subjects.
FGF18 in Sheep Lungs with Surgical Diaphragmatic Hernia and Surgical Diaphragmatic Hernia plus TO
The experimental groups were surgical diaphragmatic hernia (sDH) created at 85 days (n ϭ 6; term ϭ 145 days), sDH ϩ TO (n ϭ 4), and control group (n ϭ 5), all retrieved at 139 days of gestation. The expression level of FGF18 in sheep lungs was determined at pre-and post-translational levels. Because the ovine FGF18 cDNA sequence had not been reported previously, a first step consisted of determining it after RT-PCR amplification. Sheep lung mRNAs were retrotranscribed and amplified using two oligonucleotide primers chosen in the human and mouse/rat cDNA sequences in regions proximate to 5Ј and 3Ј ends and conserved among species described thus far. This allowed amplification of a 531-bp product representing a partial sequence of ovine FGF18 corresponding to positions 49 through 579 of the 621-nucleotide coding sequences of human, mouse, and rat FGF18 ( Figure 4A ). Its predicted amino-acid sequence shared 99% homology with human, mouse, and rat FGF18 as shown by sequence alignment ( Figure 4B ). The ovine cDNA sequence then served to design oligonucleotide primers for use in real-time RT-PCR to evaluate FGF18 expression level among the various experimental groups. We found a 60% reduction of FGF18 transcript in the lung ipsilateral to hernia in the sDH group compared with the control group ( Figure 5A ). There was a trend toward a decrease of FGF18 mRNA level in contralateral lung as well, but the difference was not statistically significant. FGF18 mRNA level was increased to twice the control level in ipsilateral and contralateral lungs in the sDHϩTO group ( Figure  5A ). FGF18 was also appraised at the posttranslational level through Western blot analysis in ipsilateral lung. FGF-18 antibody raised against the human peptide recognized ovine FGF18 at the same apparent molecular weight ( Figure 5B ). Densitometric analysis normalized for gel loading indicated values of 193.4 and 596.5, 23.3 and 70.1, and 1,381.0 and 327.5 a.u. in control subjects, sDH, and sDHϩTO, respectively. Consistent with mRNA findings, FGF18 protein was therefore decreased to very low level in sDH compared with control subjects and reestablished in sDHϩTO. Because FGFR3-FGFR4 double null mutation abolished alveolar septation in the mouse (26) and because FGFR3 is a putative receptor of FGF18 (25), expression of the transcript of FGFR3 was studied in parallel. By contrast with FGF18, FGFR3 expression was unaffected by sDH, and although it tended to increase after TO, the difference was not statistically significant ( Figure 5C ).
Elastin in Sheep Lungs with sDH and sDH؉TO
Elastin staining on sections from the lung ipsilateral to hernia showed changes in elastin deposition similar to those in human CDH. Control lungs displayed regularly distributed airspaces with thin parenchymal tissue and dense focal elastic fiber deposits localized primary at the tips of newly forming septa and lining alveolar walls (Figures 6A and 6AЈ ). All sDH lungs appeared immature with thicker septa. Some presented regularly distributed airspaces with evenly distributed elastin fibers, but, similar to human CDH lungs, secondary crests with typical punctate elastin deposit at the apex were rare ( Figure 6B ). Other subjects displayed zones of dilated airspaces among large zones of dense Definition of abbreviation: CDH ϭ congenital diaphragmatic hernia. The proportion of total lung tissue surface area represented by elastic fiber deposits was determined on tissue sections after Weigert's stain using image analysis and excluding vessel and airway elastin. Each value represents the average ratio Ϯ SE of 8 to 10 determinations in fields taken at random for one individual lung. (Original magnification: ϫ400).
and thick parenchyma, with elastin deposits being confined to dilated airspaces and extremely scarce in dense areas ( Figure  6C ). The paucity of elastin staining in dense areas and its presence at the tip of septa in dilated ones indicate that the presence of dilated and nondilated zones is not an artifactual consequence of absence of pressure fixation, but rather is a feature of these lungs. In fetuses with sDHϩTO, alveolarization seemed to be restored as indicated by the reappearance of regular elastin lining and punctate elastin deposits located at the tip of crests, which presented an appearance similar to that observed in controls ( Figures 6D and 6DЈ ). Elastin in walls of blood vessels and airways did not seem to be altered in the sDH and sDHϩTO groups. Quantification of parenchymal elastic fiber density indicated dramatically reduced amounts in sDH lungs that were only one seventh those in control lungs; TO restored the proportion of elastin deposits to a level not significantly different from that in control lungs (Table 4 ). In addition, tropoelastin mRNA level was decreased about half in ipsilateral lung in the sDH group but was unchanged in contralateral lung, and TO enhanced the level to twice that in controls in ipsilateral and contralateral lungs (Figure 7) , thus abolishing the DH effect.
Expression of Tropoelastin and FGF18 in Rat Lungs with Induced CDH and CDH ؉ Vitamin A
Nitrofen treatment resulted in lung hypoplasia in all fetuses and was associated with a 60 to 70% incidence of right-sided CDH. Lung wet weights were 111.1 Ϯ 1.0, 85.5 Ϯ 1.9, and 67.7 Ϯ 1.6 mg in control fetuses (given olive oil, the vehicle of nitrofen), nitrofen-treated fetuses without CDH, and nitrofen-treated fetuses with CDH, respectively (p Ͻ 0.001 vs. controls for both nitrofen-treated groups). Vitamin A increased lung growth without fully restoring the control level in nitrofen-treated fetuses (97.8 Ϯ 3.0 mg without CDH and 76.0 Ϯ 1.9 mg with CDH, p Ͻ 0.05 as compared with nitrofen-treated fetuses without vitamin A). Tropoelastin and FGF18 mRNAs were deeply decreased to about 13 and 17% of the control levels, respectively, in fetuses with nitrofen-induced CDH as compared with controls ( Figure 8 ). Similar decreases were observed in nitrofen-treated fetuses without CDH (not shown), suggesting an association with nitrofeninduced lung hypoplasia in the presence or absence of hernia. Vitamin A administration 2 days after nitrofen treatment prevented the drop of tropoelastin and FGF18 mRNAs that displayed levels not significantly different from those in controls (Figure 8 ).
FGF18 Immunolocalization in Lung Tissues
This investigation was performed in control lung tissues of the three species to define cell localization of FGF18. Figure 9 shows results obtained with the same anti-FGF18 antibody in distal lung tissue. Immunoreactivity appeared in parenchymal cells as a dotted labeling. Figure 9A depicts immunofluorescence micrograph of 37-week fetal human lung tissue, indicating the presence of FGF18 in septal cells. Epithelial airway cells were slightly labeled, whereas smooth muscle cells of small airways or arteries were negative. In bronchial cartilaginous plates, chondrocytes, which are known to express FGF18 (37), were also labeled (not shown). In 139-day fetal sheep lung tissue ( Figure 9C ), labeling was similarly found in the septa. Weak labeling was present in airway epithelial cells (not shown) but was absent from airway and vascular smooth muscle cells. In the rat, we studied lung Figure 9E ), when FGF18 expression has been reported to be elevated (24) . FGF18 immunoreactivity was present in cells in the thickness of walls of primary and secondary septa (left and right inserts in Figure 9E , respectively). Distribution of FGF18 labeling seemed to be similar to that of elastin or ␣-smooth muscle actin ( Figure 9G ).
DISCUSSION
We report that decreases of FGF18 expression and of elastic fiber deposition in alveolar septa characterize CDH in humans. The presence of similar features in two animal models allowed us to use the latter to evaluate the effects of potential therapeutic approaches on these abnormalities. Tracheal occlusion in the surgical model and vitamin A treatment in the nitrofen model allowed nearly normal features to be recovered. The work supports further studies to determine the potential benefit of these treatments in promoting lung growth and maturation in the presence of diaphragmatic hernia.
Limitations of the Study
Investigations in humans raise the question of control appropriateness. Only lung samples from subjects with other, nonpulmonary diseases can be used as controls. This is an unavoidable limitation of the present study that may introduce bias. For instance, FGF18 is known to be involved not only in lung development but also in the formation of heart, bone, and the central nervous system. Nevertheless, the fact that differences were demonstrated between CDH and control lungs and were observed also in animal models of CDH suggests that abnormalities result from CDH. This underlines the usefulness of comparing human and model data.
Lung Expression of FGF18 Is Deficient in Diaphragmatic Hernia
Lung hypoplasia associated with CDH is believed to result from a precocious arrest of bronchial branching (6) . The development of distal lung, including saccules and alveoli, seems to be impaired also. Disturbed alveolar development seems to be a common feature of hypoplastic lungs, including in the instance of CDH (10, 11, (15) (16) (17) . Altogether, these disorders result in the histologic appearance of less-than-stated gestational age with less acinar complexity (5) . Taking into account the recently demonstrated association of FGF18 with the alveolarization process, we investigated whether pulmonary FGF18 expression was affected in CDH lung. FGF18 was effectively shown to play a crucial role in the development of murine distal lung. Similar to features seen in mice deficient in elastin (13), fewer and larger air sacs were observed in FGF18-deficient mouse fetuses (23) . Although lethality at birth prevents one from studying alveolarization in FGF18-deficient mice, the involvement of FGF18 in secondary septation is supported by FGF18 up-regulation during the process in the rat (24) , by elastogenesis-stimulating activity of FGF18 in fibroblasts (24) , and by the crucial role of FGFR3-FGFR4 signaling for secondary septation (26) .
The expression pattern of FGF18 in the developing human lung had not been examined previously. A first step therefore consisted of studying FGF18 expression in the course of fetal lung development. A major observation of the present study was the marked increase in FGF18 protein, starting from 27 to 28 weeks of gestation and reaching an elevated level at 36 to 37 weeks. Although the precise time when secondary alveolar septation begins in humans is a matter of debate, in part because of the difficulty in defining an alveolus in microscopic sections (12) , it is generally accepted that the process starts between 30 and 36 weeks of gestation. Therefore, FGF18 increases in human lung coincidently with starting secondary septation. This finding, consistent with studies in rodents, reinforces the assumption of involvement of FGF18 in alveologenesis. Moreover, FGF18 localization in interstitial cells of alveolar walls, presumably myofibroblasts, at the sites and time of alveolarization and elastin deposition strongly argues in favor of FGF18 involvement in the process. Previous investigations had consistently indicated that FGF18 expression was located principally in interstitial tissue of distal lung areas in the mouse (22) . Furthermore, FGF18 absence from perivascular or periairway wall tissue where elastin is also abundant is in favor of specific involvement for alveolarization at this stage of lung development.
In a second step, human CDH lungs were compared with age-matched control lungs. We found a low FGF18 protein level in CDH lungs, with failure to increase in late pregnancy. Consistently, lowered FGF18 expression was found also in the ovine sDH model and in the nitrofen model in rats. The absence of change in FGFR3 expression in sDH indicates impairment of signaling at the ligand level, not at the receptor level. Secondary septation was begun in humans and advanced in sheep at stages when FGF18 was determined in CDH. Impaired expression is therefore likely to be related to the impairment of this process. In the rat, the process of secondary septation was not initiated at the stage when the study was performed. Nevertheless, elastin and FGF18 transcripts were decreased in the nitrofen model, which suggests disturbance in the prenatal formation of saccular walls. In rat lung, FGF18 presents two developmental peaks: a twofold prenatal increase between Fetal Days 19 and 21 and a sevenfold increase between postnatal Days 2 and 3, separated by a transient fall at the time of birth (24) . The changes reported here correspond to the inhibition of the first rise that may therefore be related to the building of saccular walls.
Elastic Fiber Density Is Diminished in Diaphragmatic Hernia
The deposition of elastin fibers is intrinsic to the process of saccular and alveolar wall formation. It has been assumed that septal elastin provides a critical morphogenetic force in alveolarization (12) . Consistent with previous reports, CDH lungs retained an immature appearance, and the rare location of elastin at the tip of growing crests supports deficiency in secondary septa. Similar observations in the ovine sDH model indicate that lung compression by ascended viscera precipitates these disorders. We did not examine elastin deposits histologically in rat fetuses with nitrofen-induced CDH, but a previous investigation in the same model (21) had demonstrated paucity of elastin staining in the simplified terminal airways, similar to our findings for human and sheep lungs. Decreased density of elastin fibers in the distal parenchyma of CDH lungs is a novel finding of the present investigation. It indicates that defective septation results from deficient elastin deposition. Decreased tropoelastin transcripts in the fetal sheep model indicated that impairment occurs at the pretranslational level. Reduced lung expansion induced by lung fluid drainage has been reported to decrease tropoelastin mRNA 2.5-fold (38) . Contradictory observations have been reported in the nitrofen model with decreased (Reference 21 and present data) or increased (39) tropoelastin transcripts. The reason for the discrepancy between studies is unclear but may be due to methodologic differences (21) . Moreover, reduced levels of tropoelastin transcripts in the nitrofen model were corroborated by reduction of desmosine content (indicative of cross-linked elastin) in the lung ipsilateral to hernia (21) . Although no quantitative evaluation of elastin synthesis was performed in oligohydramnios, the absence of elastin deposits in alveolar septa reported at the ultrastuctural level in hypoplastic lungs with this disease (16) also suggests defective synthesis. Impaired elastogenesis in pulmonary septa therefore presents as a common feature in underexpanded hypoplastic lungs, whatever the leading cause, and may therefore represent a direct consequence of insufficient lungtissue tension. Although the present investigation does not demonstrate a causal relationship between FGF18 changes and impairment or restoration of alveolarization, developmental lung disturbances in prenatal mice lacking FGF18 (23) and the coordinated effects of FGF18 upon various proteins involved in elastogenesis by neonatal rat lung myofibroblasts (24) strongly argue in favor of such a link. The presence of FGF18 transcripts (22) and immunoreactive FGF18 (present data) in distal lung parenchyma reinforces this hypothesis.
Treatments Restore FGF18 Expression and Elastin Deposition in CDH Models
FGF18 and elastin transcript and protein were restored or enhanced above the control level by TO in sDH and by vitamin A in the nitrofen model. It is well established that TO induces cell proliferation (40), a process enhanced for all cell types during alveolarization. A variety of growth factors have been reported to increase in the lung in response to TO, including FGF7, transforming growth factor-␤2, vascular endothelial growth factor, insulin-like growth factor-1, and insulin-like growth factor-2 (9, (41) (42) (43) (44) (45) . The notion that they play a crucial role in expansioninduced lung growth is strengthened by the observation that replacement of lung fluid, which contains growth factors, by saline prevents lung growth normally observed after TO (46) . Our finding of increased FGF18 mRNA and protein after TO indicates stimulation by lung expansion and adds FGF18 to the growth factors listed previously. With regard to elastin expression, our findings are in agreement with those from Joyce and colleagues (38) , showing a transient 2.5-fold increase of tropoelastin mRNA in the occluded fetal sheep lung. In this study, however, TO was performed on an intact lung and was not combined with diaphragmatic hernia or drainage. Restoration of elastic fiber density and of lung histologic aspect in sDH lungs indicates that TO not only restored overall lung growth but also restored secondary septation, consistent with previous observation at the ultrastructural level (20) . Data from other investigations indicate that this restoration seems to be sufficient to recover normal morphometric parameters, including radial alveolar count (27) , gas-exchange surface area, and alveolar density (28) .
The second therapeutic approach, which consisted of the use of vitamin A in the nitrofen model, is based on the importance of retinoids, including vitamin A and its active metabolites, in the alveolarization process (47) . Several studies support the hypothesis that abnormalities within the retinoid-signaling pathway contribute to the etiology of CDH (48) . Moreover, decreased plasma retinol and retinol-binding protein levels have been reported in human newborns with CDH (49) . Restoration of FGF18 and tropoelastin expressions by vitamin A in the lung of nitrofen-treated rat fetuses is in keeping with our previous finding that FGF18 and tropoelastin expression were up-regulated subsequently to vitamin A administration to normal rat neonates (24) . This suggests that the beneficial effect of vitamin A for pulmonary hypoplasia (33) might have resulted, among possible changes in other growth factors, from promotion of FGF18 expression. However, in this model, lung hypoplasia and immaturity also occur in pups that do not develop CDH. Although less marked, the morphology of lungs of fetuses without hernia was reported to be similar to that of CDH lungs, including a paucity of elastic fiber deposits in septa (21) . In agreement with this observation, we found reduced FGF18 and tropoelastin expression in nitrofen-treated fetuses devoid of hernia. Disorders could therefore result from pulmonary toxic effect(s) of nitrofen independently of CDH. Thyroid transcription factor-1, which is essential to lung morphogenesis, was down-regulated by nitrofen in fetal rat lungs independently of the presence of CDH (50) and in a time-and dose-dependent manner in cultured lung epithelial H-441 cells (51) . Nitrofen is also believed to interfere with vitamin A signaling (52, 53) . Therefore, it cannot be excluded that vitamin A supplementation counteracted some pulmonary effects of nitrofen, including FGF18 and elastin changes, that were not direct consequences of hernia. Considering the use of vitamin A as a possible treatment of lung abnormalities in CDH therefore requires further evaluation of its benefits and safety.
In conclusion, changes in FGF18 induced by CDH and treatments are novel and significant findings in the present study. Simultaneous correction of FGF18 and elastin defects by TO and vitamin A suggests that disordered alveolarization may result, at least in part, from FGF18 deficiency.
